HomeKRYS • NASDAQ
add
Krystal Biotech Inc
Previous close
$160.23
Day range
$157.90 - $164.74
Year range
$82.09 - $189.97
Market cap
4.59B USD
Avg Volume
262.64K
P/E ratio
408.97
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 42.14M | — |
Operating expense | 36.13M | 2.94% |
Net income | 8.69M | 127.12% |
Net profit margin | 20.62 | — |
Earnings per share | 0.96 | 176.59% |
EBITDA | 5.58M | 116.39% |
Effective tax rate | 18.44% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 532.18M | 40.35% |
Total assets | 818.36M | 46.54% |
Total liabilities | 39.71M | 9.65% |
Total equity | 778.64M | — |
Shares outstanding | 28.29M | — |
Price to book | 5.81 | — |
Return on assets | 0.98% | — |
Return on capital | 1.01% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 8.69M | 127.12% |
Cash from operations | -7.23M | 67.61% |
Cash from investing | -10.16M | -95.08% |
Cash from financing | 2.62M | -14.66% |
Net change in cash | -14.91M | 39.15% |
Free cash flow | -17.73M | -3.29% |
About
Founded
2015
Headquarters
Website
Employees
229